UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 31, 2014

Accession Number:	0001144204-14-015392
Submission Type:	POS AM
CIK: 0001541157 Company Name: Celsus Therapeutics Plc. File Number: 333-185247